Recalls / Class II
Class IID-1703-2019
Product
RXQ CAIN (PHENYLEP 1.5%/ LIDO 1% OPHTH SOL (PF), 1 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0918-01
- Affected lot / code info
- All lots within expiry
Why it was recalled
Lack of Assurance of Sterility
Recalling firm
- Firm
- RXQ Compounding LLC
- Notification channel
- Press Release
- Type
- Voluntary: Firm initiated
- Address
- 340 W State St Unit 9, N/A, Athens, Ohio 45701-1564
Distribution
- Quantity
- N/A
- Distribution pattern
- Nationwide USA
Timeline
- Recall initiated
- 2019-06-19
- FDA classified
- 2019-08-08
- Posted by FDA
- 2019-08-14
- Terminated
- 2022-09-16
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1703-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.